Matrix metalloproteinase biology applied to vitreoretinal disorders.
Sethi
C S
CS
Department of Pathology, Institute of Ophthalmology, and Moorfields Eye Hospital, London, UK.
Bailey
T A
TA
Luthert
P J
PJ
Chong
N H
NH
D005128:Eye Diseases / Q000201:enzymology*; D006801:Humans; D020782:Matrix Metalloproteinases / Q000737:chemistry / Q000502:physiology*; D008545:Melanoma / Q000201:enzymology; D015861:Retinal Neovascularization / Q000201:enzymology; D019714:Tissue Inhibitor of Metalloproteinases / Q000502:physiology; D014604:Uveal Neoplasms / Q000201:enzymology; D018630:Vitreoretinopathy, Proliferative / Q000201:enzymology
D019714:Tissue Inhibitor of Metalloproteinases; D020782:Matrix Metalloproteinases